ANZBMS 2019 Jeffrey Hassall
Amgen Australia, NSW, Australia
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Effect of denosumab versus risedronate on cortical and trabecular bone microarchitecture by high resolution peripheral quantitative computed tomography (HR-pQCT) in glucocorticoid-treated individuals (#88)
5:55 PM
Jeffrey Hassall
Welcome Reception and Plenary Posters
A pooled analysis of fall incidence from placebo-controlled trials of denosumab (#89)
5:55 PM
Jeffrey Hassall
Welcome Reception and Plenary Posters